BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/23/16 Reata Pharmaceuticals (RETA) Bardoxolone methyl for Diabetic Peripheral Neuropathy (DPN) Subscribers Only Subscribers Only Subscribers Only
5/23/16 Akebia Therapeutics (AKBA) Vadadustat for Anemia Due to Chronic Renal Failure, Dialysis-Dependent Subscribers Only Subscribers Only Subscribers Only
5/23/16 Sanofi (SNY) Lyxumia for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
5/23/16 Sanofi (SNY) LixiLan for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
5/23/16 Samsung Bioepis Biosimilar Infliximab (Samsung Bioepis) for Rheumatoid Arthritis (RA) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/24/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/24/16 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
05/24/16 Subscribers Only Subscribers Only Trial Data - Other
05/24/16 Subscribers Only Subscribers Only Trial Data - Other
05/24/16 Subscribers Only Subscribers Only Trial Data - Updated Results